|Bid||39.95 x 1400|
|Ask||40.00 x 3200|
|Day's range||39.31 - 39.92|
|52-week range||29.99 - 43.08|
|Beta (5Y monthly)||0.65|
|PE ratio (TTM)||23.44|
|Forward dividend & yield||1.56 (3.90%)|
|Ex-dividend date||06 May 2021|
|1y target est||N/A|
Pfizer (NYSE: PFE) and its partner BioNTech (NASDAQ: BNTX) recently announced that they plan to soon file for full U.S. Food and Drug Administration (FDA) approval for their COVID-19 vaccine. The vaccine currently has Emergency Use Authorization. In this Motley Fool Live video recorded on May 5, Motley Fool contributors Keith Speights and Brian Orelli discuss how the potential FDA approval could matter for investors.
Here's why three Motley Fool contributors believe General Dynamics (NYSE: GD), Ford Motor (NYSE: F), and Pfizer (NYSE: PFE) are solid picks for investors looking for dividend stocks they can hold for the long term. Lou Whiteman (General Dynamics): General Dynamics (GD) has flown through turbulence in recent years. General Dynamics had few units generating outside margins, and the stock trailed other large defense contractors over the past five years.
Dr. Shikha Jain, an Assistant Professor of Medicine at the University of Illinois Chicago joined Yahoo Finance to break down what the CDC's new stance on mask wearing means for vaccinated citizens.